Diffusion Tensor Imaging in Multiple Sclerosis: Assessment of Regional Differences in the Axial Plane within Normal-Appearing Cervical Spinal Cord

References

1. ↵
   Lin X, Tench CR, Turner B, et al. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon {beta}-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry 2003;74:1090–94

   Abstract/FREE Full Text
2. ↵
   Losseff N, Webb S, O’Riordan J, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996;119:701–08

   Abstract/FREE Full Text
3. ↵
   Schwartz ED, Cooper ET, Chin C-L, et al. Ex vivo evaluation of ADC values within spinal cord white matter tracts. AJNR Am J Neuroradiol 2005;26:390–97

   Abstract/FREE Full Text
4. ↵
   Valsasina P, Rocca MA, Agosta F, et al. Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients. NeuroImage 2005;26:822–28

   CrossRefPubMedWeb of Science
5. ↵
   Agosta F, Benedetti B, Rocca MA, et al. Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI. Neurology 2005;64:631–35

   Abstract/FREE Full Text
6. ↵
   Thielen KR, Miller GM. Multiple sclerosis of the spinal cord: magnetic resonance appearance. J Comput Assist Tomogr 1996;20:434–38

   CrossRefPubMedWeb of Science
7. ↵
   McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–27

   CrossRefPubMedWeb of Science
8. ↵
   Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676–95

   Abstract/FREE Full Text
9. De Stefano N, Matthews PM, Filippi M, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003;60:1157–62

   Abstract/FREE Full Text
10. ↵
    Sailer M, Fischl B, Salat D, et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003;126:1734–44

    Abstract/FREE Full Text
11. ↵
    Law M, Saindane AM, Ge Y, et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004;231:645–52

    CrossRefPubMedWeb of Science
12. Davie CA, Barker GJ, Thompson AJ, et al. ¹H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:736–42

    Abstract/FREE Full Text
13. Husted CA, Goodin DS, Hugg JW, et al. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo ³¹P and 1H spectroscopic imaging. Ann Neurol 1994;36:157–65

    CrossRefPubMedWeb of Science
14. Filippi M, Rocca MA, Minicucci L, et al. Magnetization transfer imaging of patients with definite MS and negative conventional MRI. Neurology 1999;52:845–48

    Abstract/FREE Full Text
15. Ge Y, Law M, Johnson G, et al. Preferential occult injury of corpus callosum in multiple sclerosis measured by diffusion tensor imaging. J Magn Reson Imaging 2004;20:1–7

    CrossRefPubMedWeb of Science
16. Wilson M, Tench CR, Morgan PS, et al. Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability. J Neurol Neurosurg Psychiatry 2003;74:203–07

    Abstract/FREE Full Text
17. Loevner LA, Grossman RI, Cohen JA, et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511–15

    PubMedWeb of Science
18. ↵
    Inglese M, Ge Y, Filippi M, et al. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. NeuroImage 2004;21:1825–29

    CrossRefPubMedWeb of Science
19. ↵
    Bot JCJ, Blezer ELA, Kamphorst W, et al. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 2004;233:531–40

    PubMedWeb of Science
20. ↵
    Clark CA, Werring DJ, Miller DH. Diffusion imaging of the spinal cord in vivo: estimation of the principal diffusivities and application to multiple sclerosis. Magn Reson Med 2000;43:133–38

    CrossRefPubMedWeb of Science
21. ↵
    Tsuchiya K, Katase S, Fujikawa A, et al. Diffusion-weighted MRI of the cervical spinal cord using a single-shot fast spin-echo technique: findings in normal subjects and in myelomalacia. Neuroradiology 2003;45:90–94

    PubMedWeb of Science
22. ↵
    Mamata H, Jolesz FA, Maier SE. Apparent diffusion coefficient and fractional anisotropy in spinal cord: age and cervical spondylosis-related changes. J Magn Reson Imaging 2005;22:38–43

    CrossRefPubMed
23. ↵
    Evangelou N, DeLuca GC, Owens T, et al. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain 2005;128:29–34

    Abstract/FREE Full Text
24. ↵
    Bergers E, Bot JCJ, De Groot CJA, et al. Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions. Neurology 2002;59:1766–71

    Abstract/FREE Full Text
25. ↵
    Tsuchiya K, Fujikawa A, Suzuki Y. Diffusion tractography of the cervical spinal cord by using parallel imaging. AJNR Am J Neuroradiol 2005;26:398–400

    Abstract/FREE Full Text